Literature DB >> 17553813

Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India.

Zia U Khan1, Harbans S Randhawa, Tusharantak Kowshik, Anuradha Chowdhary, Rachel Chandy.   

Abstract

BACKGROUND: We present antifungal susceptibility data on environmental isolates of Cryptococcus neoformans (serotype A, n=117) and Cryptococcus gattii (serotype B, n=65) cultured from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees.
METHODS: Susceptibilities to amphotericin B, fluconazole, ketoconazole, itraconazole and voriconazole were determined by using Etest. The MICs were read after 48 h as per the guidelines provided by the manufacturer.
RESULTS: The MIC90s and susceptibility ranges for C. neoformans isolates were as follows: 0.094 (0.004-0.25) mg/L for amphotericin B, 4 (0.032-12) mg/L for fluconazole, 0.094 (0.004-0.75) mg/L for itraconazole, 0.064 (0.002-0.19) mg/L for ketoconazole, and 0.047 (0.006-0.125) mg/L for voriconazole, whereas for C. gattii isolates these were 0.125 (0.023-0.5) mg/L for amphotericin B, 8 (0.032-16) mg/L for fluconazole, 0.75 (0.006-2) mg/L for itraconazole, 0.125 (0.003-0.19) mg/L for ketoconazole, and 0.094 (0.004-0.125) mg/L for voriconazole. A comparison of the geometric means of MICs (mg/L) revealed that C. gattii was less susceptible than C. neoformans to amphotericin B (0.075 versus 0.051, P=0.0003), fluconazole (2.912 versus 2.316, P=0.003), itraconazole (0.198 versus 0.0344, P<0.0001), ketoconazole (0.072 versus 0.037, P<0.0001), and voriconazole (0.045 versus 0.023, P<0.0001).
CONCLUSIONS: The antifungal susceptibility data obtained in this study indicate that the occurrence of primary resistance among environmental isolates of C. neoformans serotype A and C. gattii serotype B is rare, and serotype B isolates are less susceptible than serotype A isolates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553813     DOI: 10.1093/jac/dkm192

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.

Authors:  K Datta; P Rhee; E Byrnes; G Garcia-Effron; D S Perlin; J F Staab; K A Marr
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

2.  Heteroresistance of Cryptococcus gattii to fluconazole.

Authors:  A Varma; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

3.  Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.

Authors:  George R Thompson; Nathan P Wiederhold; Annette W Fothergill; Ana C Vallor; Brian L Wickes; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 4.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

5.  Diagnosis of Cryptococcosis and Prevention of Cryptococcal Meningitis Using a Novel Point-of-Care Lateral Flow Assay.

Authors:  Ashar Dhana
Journal:  Case Rep Med       Date:  2013-11-12

6.  Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.

Authors:  Ruchi Sethi Gutch; Shesh Rao Nawange; Shankar Mohan Singh; Ruchika Yadu; Aditi Tiwari; Richa Gumasta; Arvind Kavishwar
Journal:  Braz J Microbiol       Date:  2015-10-27       Impact factor: 2.476

7.  Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche.

Authors:  Kausik Datta; Karen H Bartlett; Kieren A Marr
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-01-15

Review 8.  Ecoepidemiology of Cryptococcus gattii in Developing Countries.

Authors:  Patricia F Herkert; Ferry Hagen; Rosangela L Pinheiro; Marisol D Muro; Jacques F Meis; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2017-11-03

9.  A New Lineage of Cryptococcus gattii (VGV) Discovered in the Central Zambezian Miombo Woodlands.

Authors:  Rhys A Farrer; Miwha Chang; Michael J Davis; Lucy van Dorp; Dong-Hoon Yang; Terrance Shea; Thomas R Sewell; Wieland Meyer; Francois Balloux; Hannah M Edwards; Duncan Chanda; Geoffrey Kwenda; Mathieu Vanhove; Yun C Chang; Christina A Cuomo; Matthew C Fisher; Kyung J Kwon-Chung
Journal:  mBio       Date:  2019-11-12       Impact factor: 7.867

10.  Prevalence, Genetic Structure, and Antifungal Susceptibility of the Cryptococcus neoformans/C. gattii Species Complex Strains Collected from the Arboreal Niche in Poland.

Authors:  Magdalena Florek; Agnieszka Korzeniowska-Kowal; Anna Wzorek; Katarzyna Włodarczyk; Maja Marynowska; Aleksandra Pogorzelska; Maria Brodala; Sebastian Ploch; Daniel Buczek; Katarzyna Balon; Urszula Nawrot
Journal:  Pathogens       Date:  2021-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.